Whanin Pharm (016580) — Working Capital to Net Assets Ratio
Whanin Pharm (016580) has a Working Capital to Net Assets ratio of 43.2% as of June 2026. Working capital of ₩183.73 Billion (current assets of ₩240.14 Billion minus current liabilities of ₩56.40 Billion) is measured against net assets of ₩425.47 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Whanin Pharm (016580) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Whanin Pharm Working Capital to Net Assets (2009–2025)
This chart shows how Whanin Pharm's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2009 to 2025. As of June 2026, the ratio stands at 43.2%, reflecting working capital of ₩183.73 Billion against net assets of ₩425.47 Billion KRW. For the complete balance sheet picture, see 016580 asset base.
Annual Working Capital to Net Assets for Whanin Pharm (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Whanin Pharm from 2009 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 016580 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.8% | ₩171.77 Billion | ₩421.01 Billion | ₩228.27 Billion | ₩56.50 Billion | ▼ -1.5 pp |
| 2024 | 42.3% | ₩158.92 Billion | ₩376.00 Billion | ₩201.30 Billion | ₩42.38 Billion | ▼ -5.8 pp |
| 2023 | 48.0% | ₩172.07 Billion | ₩358.21 Billion | ₩212.10 Billion | ₩40.03 Billion | ▼ -1.6 pp |
| 2022 | 49.6% | ₩165.67 Billion | ₩333.93 Billion | ₩197.42 Billion | ₩31.75 Billion | ▼ -17.1 pp |
| 2021 | 66.7% | ₩211.51 Billion | ₩317.23 Billion | ₩242.41 Billion | ₩30.90 Billion | ▲ +3.4 pp |
| 2020 | 63.3% | ₩187.63 Billion | ₩296.60 Billion | ₩214.35 Billion | ₩26.72 Billion | ▼ -2.4 pp |
| 2019 | 65.7% | ₩180.23 Billion | ₩274.46 Billion | ₩204.98 Billion | ₩24.74 Billion | ▲ +2.4 pp |
| 2018 | 63.2% | ₩164.18 Billion | ₩259.58 Billion | ₩187.83 Billion | ₩23.66 Billion | ▲ +4.1 pp |
| 2017 | 59.2% | ₩143.83 Billion | ₩243.08 Billion | ₩171.81 Billion | ₩27.99 Billion | ▼ -6.0 pp |
| 2016 | 65.1% | ₩143.39 Billion | ₩220.13 Billion | ₩163.49 Billion | ₩20.10 Billion | ▼ -7.5 pp |
| 2012 | 72.6% | ₩118.00 Billion | ₩162.53 Billion | ₩131.47 Billion | ₩13.47 Billion | ▲ +0.4 pp |
| 2011 | 72.2% | ₩108.17 Billion | ₩149.85 Billion | ₩119.34 Billion | ₩11.18 Billion | ▼ -8.7 pp |
| 2009 | 80.9% | ₩87.70 Billion | ₩108.44 Billion | ₩96.86 Billion | ₩9.16 Billion | — |